Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01163552 · ClinicalTrials.gov registry record · Phase 2

Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity

A Phase 2 study of Breast Cancer and Ovarian Cancer, sponsored by St. Luke's-Roosevelt Hospital Center.

Completed
Registry status
Phase 2
Development phase
5
Enrollment target
1
Study location

NCT01163552: Completed Phase 2 study of Breast Cancer and Ovarian Cancer, sponsored by St. Luke's-Roosevelt Hospital Center.

NCT01163552 is a Phase 2 study of Breast Cancer and Ovarian Cancer that has completed, run by St. Luke's-Roosevelt Hospital Center. The registered enrollment target is 5 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01163552, a Phase 2 study of Breast Cancer and Ovarian Cancer, has completed, sponsored by St. Luke's-Roosevelt Hospital Center.

COMPLETED
Registry status
Phase 2
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

Cancers that have spread to the inner lining of the chest are classified as Stage IV and bear a poor prognosis. Surgery is rarely an option, with palliative chemotherapy and/or radiation therapy the only treatment options. This study intends to evaluate whether surgical removal of all visible tumor on the chest wall followed by bathing the chest cavity in heated chemotherapy solution will improve outcomes for these advanced cancers.

Primary Outcome

Most cancers that have spread to the chest cavity have limited survival. Response to systemic chemotherapy and radiation therapy is short-lived. This end point will determine the time to disease progression of this experimental treatment modality.

Conditions Studied

Breast Cancer Ovarian Cancer Colon Cancer Uterine Cancer Renal Cell Cancer Thymic Cancer Pleural Metastases

Interventions

  • PROCEDURE Surgical debulking and Intrathoracic Hyperthermic Chemotherapy

Study Locations (1)

New York

  • St. Luke's-Roosevelt Hospital Center - New York

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2010-06
Est. Completion 2014-05
Phase Phase 2
St. Luke's-Roosevelt Hospital Center

57 total trials

What the finished NCT01163552 record still lists

NCT01163552 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower).

The record links to 7 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Surgical debulking and Intrathoracic Hyperthermic Chemotherapy is the first listed.

NCT01163552 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT01163552 about?

NCT01163552 is a clinical study titled "Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity". Cancers that have spread to the inner lining of the chest are classified as Stage IV and bear a poor prognosis. Surgery is rarely an option, with palliative chemotherapy and/or radiation therapy the only treatment options. This study intends to evaluate whether surgical removal of all visible tumor ...

What is the current status of trial NCT01163552?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2010-06. Estimated completion is 2014-05.

What conditions does trial NCT01163552 study?

This clinical trial studies the following conditions: Breast Cancer, Ovarian Cancer, Colon Cancer, Uterine Cancer, Renal Cell Cancer.

What interventions are being tested in trial NCT01163552?

The interventions under investigation include: Surgical debulking and Intrathoracic Hyperthermic Chemotherapy (PROCEDURE).

Who is sponsoring clinical trial NCT01163552?

This trial is sponsored by St. Luke's-Roosevelt Hospital Center, which has 57 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01163552 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01163552's enrollment target sits among peer trials

5 1211th of 1224 higher than 11 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT01163552, the US trial registry maintained by the National Library of Medicine. NCT01163552 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.